ArticleRheumatology and therapy2023

Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.

Hua Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.